Search

everythinglearnresearchcommunity

for

Search:↓

Sintilimab with chemotherapy improves survival and response in advanced lung cancer but increases some side effects.

RADA16-I can effectively deliver and release mangiferin, improving its solubility and bioavailability.

Intralesional triamcinolone acetonide can effectively limit the progression of GLPLS.

Drug approvals slowed in 2Q22, but notable drugs like Amvuttra, Camzyos, and Olumiant were approved.

Biosimilars lower costs but don't significantly improve access.

Microneedling with topical dutasteride improves hair growth in men with hair loss and is safe to use.

A parasite molecule can speed up skin healing and reduce scarring.

The fish oil-based gel with imiquimod improves skin cancer treatment and reduces inflammation.

Oral bicalutamide is safe and effective for female hair loss.

Microneedle-delivered polyglutamate effectively and safely improves hair growth in androgenetic alopecia.

The combination of tadalafil and finasteride improves urinary symptoms and erectile function in men with enlarged prostates.

The new gel for hair loss is safe, effective, and reduces side effects.

A man developed skin lesions as a side effect of a gamma secretase inhibitor used for treating a tumor.

Janus Kinase inhibitors are effective and have an acceptable safety profile for treating moderate to severe Ulcerative Colitis.

Lack of TG2 increases fat storage and lowers cell cleanup in skin oil cells.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

Rezpegaldesleukin shows promise for treating severe alopecia areata.

Minimally invasive glaucoma surgery can effectively manage glaucoma in GAPO syndrome when other treatments fail.

Clofazimine effectively treated ashy dermatosis in a patient.

Upadacitinib may effectively treat both alopecia universalis and Crohn's disease.

The new drug delivery system improves exemestane's absorption and effectiveness.

Changes in SHBG levels don't predict diabetes risk reduction.

Ixekizumab helps improve life quality, physical ability, and work performance in patients with psoriatic arthritis who haven't used biologic drugs before.

Many drugs can cause lipid metabolism issues, and labels need better warnings.

Upadacitinib significantly improved alopecia universalis and psoriatic arthritis in a patient.

Dalpiciclib is the safest and most satisfying CDK4/6 inhibitor for advanced breast cancer patients in China.

A new topical treatment using micelles shows promise for safer and more effective hair regrowth in androgenetic alopecia.

The drug TGU was ineffective against small cell lung cancer and caused significant bone marrow suppression.

Trastuzumab deruxtecan is effective for advanced breast cancer but has side effects like nausea and fatigue.

Janus Kinase inhibitors effectively induce remission in Ulcerative Colitis with an acceptable safety profile.